Ralf Kuriyel
Chief Tech/Sci/R&D Officer bei REPLIGEN CORPORATION
Vermögen: 3 Mio $ am 31.03.2024
Profil
Zurzeit ist Ralf Kuriyel Senior Vice President-Research & Development bei Repligen Corp. In der Vergangenheit war er Vice President-Research & Development für Pall Life Sciences und Vice President-Field Applications R&D bei Pall Corp. Herr Kuriyel hat einen Bachelor- und einen Master-Abschluss vom Rensselaer Polytechnic Institute.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLIGEN CORPORATION
0,03% | 18.03.2024 | 17 719 ( 0,03% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Ralf Kuriyel
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18.10.2016 |
Ehemalige bekannte Positionen von Ralf Kuriyel
| Unternehmen | Position | Ende |
|---|---|---|
| PALL CORPORATION | Corporate Officer/Principal | 01.10.2016 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Chief Tech/Sci/R&D Officer | 01.10.2016 |
Ausbildung von Ralf Kuriyel
| Tufts University | Doctorate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |
